c-erbB3 and c-erbB4 expression is a feature of the endocrine responsive phenotype in clinical breast cancer

Oncogene

Volumn 17, Issue 15, 1998, Pages 1949-1957

  Knowlden, J M ^a   Gee, J M W ^a   Seery, L T ^a   Farrow, L ^a   Gullick, W J ^b   Ellis, I O ^c   Blamey, R W ^c   Robertson, J F R ^c   Nicholson, R I ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

^c NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

c erbB3; c erbB4; Cell proliferation; EGFR; Endocrine response; ER; RT PCR

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN RECEPTOR; KI 67 ANTIGEN; MESSENGER RNA;

ARTICLE; BREAST CANCER; CLINICAL ARTICLE; FEMALE; GENE EXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; ONCOGENE C ERB; PHENOTYPE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0032532214     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1202107     Document Type: Article

References (49)

1. Alimadi M, Romano A, Curia MC, Muraro R, Fedi P, Aaronson SA, Difiorr PP, Kraus MH. (1995) Oncogene., 10, 1813-1821.
2. Bacus SS, Huberman E, Chin D, Kiguchi K, Simpson S, Lippman M and Lupu R. (1992). Cell Growth & Diff., 3, 401-411.
3. Bacus SS, Gudkov AV, Zelnick CR, Chin D, Stern R, Stern R, Stancovski I, Peles E, Baruch B, Farbstein H, Lupu R, Wen D, Sela M and Yarden Y. (1993). Cancer Res., 53, 5251-5261.
4. Brotherick I, Shenton BK, Angus B, Waite IS, Horne CH and Lennard TW. (1995). Cancer Immunol. Immunotherapy., 41, 280-286.
5. Carraway KL and Cantley LC. (1994). Cell, 78, 5-8.
6. Chan SDH, Antoniucci DM, Fok KS, Alajoki ML, Harkins RN, Thompson SA and Wada HG. (1995). J. Biol. Chem., 270, 22608-22613.
7. Daffada AAI, Johnson SRD, Nicholls J, Dowsett M. (1994). J. Mol. Endocrinol., 13, 265-273.
8. Earp HS, Dawson TF, X Li and H Yu. (1995). Breast Cancer Res. Treat., 35, 115-132.
9. Fantl WJ, Johnson DE and Williams LT. (1993). Annal. Rev. Biochem., 62, 453-481.
10. Fedi P, Pierce JH, Difiore PP and Kraus MH. (1994). Mol. Cell. Biol., 14, 492-500.
11. Frye RA, Benz CC and Edison L. (1989). Oncogene, 4, 1153-1157.
12. Fuqua SAW, Falette NF and McGuire WL. (1990). J. Natl. Cancer Inst., 82, 858-861.
13. Gasparini G, Gullick WJ, Maluta S, Palma PD, Caffo O, Leonardo E, Boracchi P, Pozza F, Lemoine NR and Bevilacqua P. (1994). Eur. J. Cancer, 30A, 16-22.
14. Gee JMW, Robertson JFR, Ellis IO, Willsher P, McClelland RA, Hoyle HB, Kyme S, Finlay P, Blamey RW and Nicholson RI. (1994). Int. J. Cancer, 59, 619-628.
15. Gee JMW, McClelland RA and Nicholson RI. (1996). In: Hormone-Dependent Cancer. Pasqualini JR, Katzenellenbogen BS (eds). Marcell Decker Publishing: USA, pp. 169-197.
16. Gerdes J, Lemke H and Baisch H. (1984). J. Immunol., 133, 1710-1715.
17. Grunt TW, Seceda M, Martin MB, Lupu R, Dittrich E, Krupitza G, Harant H, Huber H and Dittrich C. (1995). Int. J. Cancer, 63, 560-567.
18. Gullick WJ. (1996). Cancer Surveys, 27, 339-349.
19. Guy PM, Platko JV, Cantley LC, Cerione RA and Carraway KL. (1994). Proc. Natl. Acad. Sci. USA, 91, 8132-8136.
20. Hayward JL, Carbonic PP, Heuston JC, Kumaoka S and Rubens RD. (1977). Cancer, 39, 1289-1293.
21. Jordan VC. (1993). Br. J. Pharmacol., 110, 507-517.
22. Klijn JGM, Berns PMJJ, Schmitz PIM and Foekens JA. (1992). Endocrine Revs., 13, 3-17.
23. Knowlden JM, Gee JMW, Bryant S, McClelland RA, Manning DL, Mansel R, Ellis IO, Blamey RW, Robertson JFR and Nicholson RI. (1997). Clin. Cancer Res., 3, 2165-2172.
24. Kraus MH, Fedi P, Starks V, Muraro R and Aaronson SA. (1993). Proc. Natl. Acad. Sci. USA, 90, 2900-2904.
25. Lemoine NR, Barnes DM, Hollywood CM, Hughes CM, Smith P, Dublin E, Prigent SA, Gullick WJ and Hurst HC. (1992). Br. J. Cancer, 66, 1116-1121.
26. Lonardo F, Marco ED, King CR, Pierce JH, Segatto O, Aaronson SA and Di Fiore PP. (1990). New Biol., 2, 992-1003.
27. Manning DL, McClelland RA, Knowlden JM, Bryant S, Gee JMW, Green CD, Robertson JF, Blamey RW, Sutherland RL, Ormandy CJ and Nicholson RI. (1995). Acta Oncologica, 5, 641-646.
28. McCarty Jr KS, Miller LS, Cox EB, Konrath J and McCarty KS. (1985). Arch. Path. Lab. Med., 109, 716-721.
29. Nicholson RI, Bouzubar KW, Walker KJ, McClelland R, Dixon AR, Robertson JFR, Ellis IO and Blamey RW. (1991). Eur. J. Cancer, 27, 908-913.
30. Nicholson RI, Eaton CL and Manning DL. (1992). In: Recent Advances In Endocrinology Metabolism. Edwards CRW, Lincoln DW (eds). Churchill Livingstone: Edinburgh, pp. 150-165.
31. Nicholson RI, McClelland RA, Finlay P, Eaton CL, Gullick WL, Dixon AR, Robertson JFR, Ellis IO and Blamey RW. (1993). Eur. J. Cancer, 29A, 1018-1023.
32. Nicholson RI, McClelland RA, Gee JMW, Manning DL, Cannon P, Robertson JFR, Ellis IO and Blamey RW. (1994). Breast Cancer Res. Treat., 29, 117-125.
33. Nicholson RI and Gee JMW. (1996). In: Hormones and Cancer. Vedeckis WV (ed.). Birkhauser: Boston, pp. 227-264.
34. O'Brian JP, Frye RA, Cogswell PC, Neubauer A, Kitch B, Prokop C, Espinosa R, Le Beau MM, Earp HS and Liu ET. (1991). Mol. Cell. Biol., 11, 5016-5031.
35. Osborne CK, Coronado E, Allred DC, Wiebe V and DeGregorio MA. (1991). J. Natl. Cancer Inst., 83, 1477-1482.
36. Peles E, Ben-Levy R, Tzahar E, Liu N, Wen D and Yarden Y. (1993). EMBO J., 12, 961-971.
37. Plowman GD, Green JM, Culouscou JM, Carlton GW, Rothwell VM and Buckley S. (1993a). Nature, 366, 473-475.
38. Plowman GD, Culouscou JM, Whitney GS, Green JM, Carlton GW, Foy L, Neubauer MG and Shoyab M. (1993b). Proc. Natl. Acad. Sci. USA, 90, 1746-1750.
39. Prigent SA and Lemoine NR. (1992). Proc. Growth Factor Res., 4, 1-24.
40. Prigent SA and Gullick WJ. (1994). EMBO J., 13, 2831-2841.
41. Rajkumar T, Gooden CS, Lemoine NR and Gullick WJ. (1993). J. Pathol., 170, 271-278.
42. Rajkumar T and Gullick WJ. (1994). Br. J. Cancer, 70, 459-465.
43. Rajkumar T, Hollywood DP, Hurst HC and Gullick WJ. (1995). The Breast, 4, 84-91.
44. Riese DJ, van Raaij TM, Plowman GD, Andrews GC and Stern DF. (1995). Mol. Cell. Biol., 15, 5770-5776.
45. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A and McGuire WL. (1987). Science, 235, 177-182.
46. Soltoff SP, Carraway KL, Prigent SA, Gullick WG and Cantley LC. (1994). Mol. Cell. Biol., 14, 3550-3558.
47. Tzahar E, Waterman H, Chen X, Levkowitz G, Karunagaran D, Lavi S, Ratzkin BJ and Yarden Y. (1996). Mol. Cell. Biol., 16, 5276-5287.
48. Wallasch C, Weib FU, Niederfellner G, Jallal B, Issing W, Ullrich A. (1995). EMBO Journal., 14, 4267-4275.
49. Wolf DM and Jordan VC. (1993). Breast Cancer Res. Treat., 27, 27-40.